Welcome - Home - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Viewing report Order by Fax Printer Friendly PDF Brochure Send to Friend Enquire before Buying Electronic Disease and Therapy Review: Non-Small Cell Lung Cancer Timely Data Resources, Inc., Dec 2006, Pages: 9   Description     Table of Contents        Enquire before Buying    Send to a Friend   The Non-Small Cell Lung Cancer (NSCLC) Disease and Therapy Review provides incidence and prevalence numbers and percentages for major countries worldwide, information on diagnosis and staging, and an overview of treatments by disease stage. General sales information is included for several chemotherapy agents, although not broken out for NSCLC specifically. Disease and Therapy Reviews were developed to provide a basic understanding of the key facts about a disease and market in a quick, easy-to-read format. These reports are prepared by a senior market research team. Each Disease and Therapy Review provides a concise analysis of the most important information about a particular disease, its treatment, and the market opportunities. Reports begin with an overview of the condition, and also contain tables that summarize the available worldwide incidence and prevalence data for the condition, a review of current diagnosis strategies and treatment options, general information about the market size, and information about important market trends. The data contained in these reports comes from key industry secondary data sources, such as the Timely Data Resources Incidence and Prevalence Database, and Langes Current Medical Diagnosis and Treatment. This information is supplemented by reviews of analyst reports, company reports, and medical websites.  Sources and references are provided. Customers who bought this item also bought Targeted Therapeutics in Non-Small Cell Lung Cancer Non-Small Cell Lung Cancer - Avastin to Lead the Market Drugs of Tomorrow 2001: Lung Cancer Treatment Algorithms 2001: Lung Cancer Emerging Therapeutics in the U.S. Non-small Cell Lung Cancer Markets Cancer Therapy US Market Survey: Analysis and Forecast - Technology, Sales and Company Profiles Cancer Therapy Worldwide Market Survey: Analysis and Forecast - Technology, Sales and Company Profiles Stakeholder Insight: Non-Small Cell Lung Cancer - The Need for Greater Product Differentiation in an Increasingly Crowded Market

		Top of page

All rights reserved. � Copyright 2008 Research and Markets    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster